Emulate Stock

Emulate’s plan is to invest more heavily in R&D, and create specific organ-on-a-chip applications that they’ve homed in on through conversations with drug companies. So far, Emulate counts 21 major drug companies, including Genentech andJohnson & Johnson as customers.

Emulate has secured a $36 million Series C financing round led by Founders Fund for commercialization of the Human Emulation System™.

Emulate, which creates living products for understanding how diseases, medicines, chemicals, and foods affect human health, raised $36m